Nell Kirchberger

7PUBLICATIONS
99CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Predictive and prognostic markersInnate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti-PD-1 Efficacy in Transgenic Mammary Tumors.

Amanda Poissonnier, Hope S Rugo, Wesley Horton

|Feb 12, 2026
ImmunoPheno: A Computational Framework for Data-Driven Design and Analysis of Immunophenotyping Experiments.

Lincoln Wu, Minh A Nguyen, Zhangliang Yang

|Oct 23, 2025
Neoplastic Immune Mimicry Potentiates Breast Tumor Progression.

Eric B Berens, Sokchea Khou, Elaine T Huang

|Apr 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

Yifei Guo, Jennifer M Finan, Alexandra Q Bartlett

|Jan 09, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer.

Jason M Link, Jennifer R Eng, Carl Pelz

|Jul 03, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections.

Ryan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai

Pageof 2

Frequent Collaborators

7 joint publications

Lisa M Coussens

6 joint publications

Shamilene Sivagnanam

2 joint publications

Konjit Betre

2 joint publications

Rosalie C Sears